Upgrade to SI Premium - Free Trial

Pacira Pharma (PCRX) Confirms FDA EXPAREL Briefing Docs Posted

February 12, 2018 1:31 PM
Pacira Pharmaceuticals, Inc. (NASDAQ: PCRX) today announced that the U.S. Food and Drug Administration (FDA) has posted briefing materials for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Trader Talk

Next Articles